Evotec SE and Novo Nordisk have announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease. The two companies will jointly identify and develop novel targets based on comprehensive medical and molecular data sets of thousands of chronic kidney disease patients. The collaboration intends to pursue the most relevant human disease biology in a therapeutic modality-agnostic approach to develop first-in-class therapeutics ...